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The maturation of glutamatergic synapses in the CNS is reg-
ulated by NMDA receptors (NMDARs) that gradually change
from a GluN2B- to a GluN2A-dominated subunit composition
during postnatal development. Here we show that NMDARs
control the activity of the smallGTPaseADP-ribosylation factor
6 (Arf6) by consecutively recruiting two related brefeldin A-re-
sistant Arf guanine nucleotide exchange factors, BRAG1 and
BRAG2, in a GluN2 subunit-dependent manner. In young cor-
tical cultures, GluN2B and BRAG1 tonically activated Arf6. In
mature cultures, Arf6 was activated through GluN2A and
BRAG2 upon NMDA treatment, whereas the tonic Arf6 activa-
tion was not detectable any longer. This shift in Arf6 regulation
and the associated drop in Arf6 activity were reversed by a
knockdown of BRAG2. Given their sequential recruitment dur-
ing development, we examined whether BRAG1 and BRAG2
influence synaptic currents in hippocampal CA1 pyramidal
neurons using patch clamp recordings in acute slices frommice
at different ages.ThenumberofAMPAreceptor (AMPAR)min-
iature events was reduced by depletion of BRAG1 but not by
depletion of BRAG2 during the first 2 weeks after birth. In con-
trast, depletion of BRAG2 during postnatal weeks 4 and 5
reduced the number of AMPAR miniature events and compro-
mised the quantal sizes of both AMPAR and NMDAR currents
evoked at Schaffer collateral synapses. We conclude that both
Arf6 activation through GluN2B-BRAG1 during early develop-
ment and the transition from BRAG1- to BRAG2-dependent
Arf6 signaling induced by the GluN2 subunit switch are critical
for the development of mature glutamatergic synapses.
Although fast excitatory neurotransmission in the central
nervous system is mediated by synapses containing both
AMPARs4 and NMDARs, developing synapses are often
AMPAR-silent and rely on NMDARs only (1). NMDARs gov-
ern the functional maturation of glutamatergic synapses as well
as activity-dependent alterations of their strength by changing
membrane trafficking that affects the AMPAR content of the
postsynaptic membrane (2).
NMDARs assemble as tetramers from two GluN1 and two
GluN2/GluN3 subunits (2). A variety of four GluN2 subunits
forms the basis for the functional diversity of the receptor.
Whereas embryonic NMDARs contain GluN2B or GluN2D,
GluN2A is increasingly expressed only during postnatal devel-
opment (3–5) and incorporated into NMDARs of synapses
receiving a strong activity (6). This developmental GluN2 sub-
unit switch prevents premature formation of synapses but
allows synapsematuration at sites of strong input (7–9). GluN2
subunits possess large intracellular domains and interact
directly or indirectly with core components of the postsynaptic
density (PSD) including PSD-95 family proteins and a number
of signaling molecules including kinases, phosphatases,
GTPases, and their regulators (10). The NMDAR channel
mediates influx of calcium ions that act as second messenger
moleculeswithin the dendritic spine and are intimately coupled
to neuronal plasticity processes (2).
Among the proteins strongly enriched in the PSD are BRAG1
and BRAG2, two closely related guanine nucleotide exchange
factors (GEFs) for the small GTPase Arf6 (11–14). BRAG pro-
teins contain a Sec7 domain catalyzing theGDP-GTP exchange
in tandem with a pleckstrin homology domain and an IQ-like
motif that binds calcium-free calmodulin (15). Arf6 regulates
membrane trafficking and actin cytoskeleton remodeling at the
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plasma membrane (16, 17). Experiments in primary neuronal
cultures indicated that Arf6 influences the maturation and
maintenance of dendritic spines (18, 19) and that a significant
fraction ofAMPARs recycles throughArf6-positive endosomes
(20).
BRAG proteins have been implicated in neuronal develop-
ment and plasticity (21).Mutations in the gene for BRAG1were
identified as the cause ofX chromosome-linked intellectual dis-
ability in several families (22). Viral expression of BRAG1 in
hippocampal slice cultures reduced evoked AMPAR currents
depending on endogenous NMDAR activity (15). We found
BRAG2 to be involved in different forms of long term depres-
sion (LTD) in the mouse hippocampus (13). LTD triggered
through metabotropic glutamate receptors relied on a direct
binding of BRAG2 to the AMPAR subunit GluA2 (13).
Here, we studied a link among NMDAR activity, BRAG-me-
diated Arf6 activation, and synaptic maturation. Our results
show that BRAG1 and BRAG2 are consecutively recruited by
NMDARs during development and that a loss of BRAG1 or
BRAG2 affects the number and strength of excitatory synapses.
Experimental Procedures
DNA Constructs—The cDNAs encoding fragments of the
intracellular domains of GluN2A and GluN2B were inserted
into pGEX-6P plasmids. Golgi-associated, -adaptin ear-con-
taining, Arf-binding protein 3 (GGA3) fused to GST for
Arf6GTP-specific pulldown assays was expressed from pGEX-
GGA3 (13). CMV expression constructs (23) for rat GluN1, rat
GluN2A, and mouse GluN2B were kindly provided by Peter H.
Seeburg. HA-tagged versions contain amino acids (aa) YPYD-
VPDYA between aa 27 and 28 of immature GluN2A and
between aa 28 and 29 of immature GluN2B. Mutations were
introduced by overlap-extension PCR and sequenced by LGC
Genomics. The cDNAs for rat BRAG1 (1154-amino acid
isoform; aa 1–1151 of GenBankTM accession number
NM_001277425 followed by aa VCY (GenBank accession num-
berNM_001277386)) and rat BRAG2 (947-amino acid isoform;
aa 1–933 of GenBank accession number NP_001127856 (Mus
musculus) followed by aa FQPFQPSQPPVLCS) (13) were
inserted into the CMV expression vector (23) in fusion with an
N-terminal FLAG epitope. The rat cDNA for Arf6 was inserted
into the CMV expression vector (23). HA-tagged Arf6 was
expressed from pcDNA-Arf6-HA (13).
Viral Constructs—Double-stranded oligonucleotide adap-
tors for BRAGRNAiwere first inserted into pCMV-U6 (24) and
evaluated for knockdown efficiency and specificity in HEK293
cells. BRAG1-RNAi, BRAG2-RNAi, and BRAG-RNAi control
(ctrl) encode the following short hairpin RNAs (5–3): GGA-
AGCUAUCUAUCGGGAUAAGUGAAGCCACAGAUGUU-
AUCCCGAUAGATAGCUUCC (B1-RNAi), GCAUUGUGC-
UGUCCAACAUGAGUGAAGCCACAGAUGUCAUGUUG-
GACAGCACAAUGC (B2-RNAi) (13), and GCAGCUAAUG-
GCCUUUCAUGAGUGAAGCCACAGAUGUCAUGAAAG-
GCCAUUAGCUGC (ctrl-RNAi; scrambled version of
B2-RNAi).
The U6-promoter-shRNA cassettes were then inserted into
pFUGW, and lentivirus was produced, concentrated, and
titered as described (13). For RNAi against both BRAG2 and
BRAG1, the U6-promoter-shRNA cassettes were inserted in
tandem (25). RNAi-mediated knockdown of endogenous
BRAG1 and BRAG2 in neuronal cultures was evaluated by
Western blotting (Figs. 4D and 5C). Cre expression vector
FCKiGW (Flap, CaMKII promoter, internal ribosome entry
site, GFP,WPRE)-Cre has been described before (13). Plasmids
for lentiviral vectors (26) and RNAi (24) were provided by Dr.
Carlos Lois and Dr. Pavel Osten.
Adeno-associated virus (AAV) constructs were generated by
insertingNheI-BstBI fragments encompassing theU6-promot-
er-shRNA cassettes for BRAG1- and BRAG2-RNAi into
pAAV-CAG-GFP (Addgene) equipped with an appropriate
linker immediately upstream of the CAG-GFP cassette. Viral
particles of AAV serotype 9 were produced by the Viral Core
Facility of the Charité Berlin using an iodixanol gradient for
purification (27) and quantitative PCR for quantification.
Antibodies—Antibodies to Arf6 (ab49931, Abcam), BRAG1
(sc-168198, Santa Cruz Biotechnology; HPA003973, Sigma-
Aldrich), FLAG (F1804 and F7425, Sigma-Aldrich), GFP
(ab13970, Abcam), GluA2 (MAB397, Millipore), GluN1
(11711, Synaptic Systems), GluN2A (07-632, Millipore),
GluN2B (sc-9057, Santa Cruz Biotechnology), HA (HA.11,
Covance), Homer1b/c (ab97593, Abcam), PSD-95 (MAB1596,
Millipore), -tubulin (T9026, Sigma-Aldrich), III-tubulin
(TUJ1, Covance), and vesicular glutamate transporter 1
(VGLUT 1) (135304, Synaptic Systems) were purchased. The
antibody to BRAG2 used for immunoblots was described pre-
viously (13). The antibody to BRAG2 used for immunocyto-
chemistry (BRAG2 IC) was generated at BioGenes (Germany)
by immunization of a rabbit with a bacterially expressed GST
fusion protein containing a 187-amino acid fragment ofmurine
BRAG2 (aa GPEK–RPEP). The resulting antiserum was first
cleaned by incubation with a matrix containing GST fused to a
189-amino acid fragment of murine BRAG1 (aa EYEK–CRDF)
and then affinity-purified on a matrix containing the protein
used for immunization.
Cell Culture—Media and supplements were obtained from
Life Technologies unless otherwise stated. Primary cortical
neurons were prepared from rat embryos at embryonic day 18
(E18). Primary hippocampal neurons were prepared from E18
rat and E16.5 mouse embryos. Cortices and hippocampi were
isolated in Hanks’ balanced salt solution, dissociated with 1
mg/ml trypsin (Worthington), and trituratedwith fire-polished
Pasteur pipettes. The cell suspension was washed twice in
growthmedium (Neurobasalmedium, B-27 serum-free sup-
plement, penicillin (50 units/ml), streptomycin (50 g/ml), 2
mM GlutaMAX) and plated on poly-DL-ornithine hydrobro-
mide (Sigma-Aldrich)-coated plates or coverslips. Cortical
neurons were plated at a density of 700,000 cells/well in 6-well
plates and 350,000/per well in 12-well plates, whereas hip-
pocampal neurons were plated on 12-mm coverslips placed in
24-well plates at 75,000 cells/well. Half of the medium was
exchanged on day in vitro 2 (DIV2), DIV4, DIV9, and then once
a week.
HEK293, HEK-BRAG1, and HEK-BRAG2 cells were main-
tained at 37 °C, 5% CO2 in DMEM (4.5 mg/ml glucose, Gluta-
MAXTM, pyruvate) supplemented with 10% FBS (Biochrom),
100 units/ml penicillin, and 100 g/ml streptomycin. Medium
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for HEK-BRAG1 and -BRAG2 cells was complemented with
150g/ml hygromycin. HEK-BRAG2 cells were plated on poly-
L-lysine-coated dishes for transfections. HEK293FT cells used
for lentivirus production were maintained at 37 °C, 5% CO2 in
DMEM (4.5 mg/ml glucose, L-glutamine), 10% FBS, 100
units/ml penicillin, 100 g/ml streptomycin, 500 g/ml gene-
ticin, 1mM sodiumpyruvate, and non-essential amino acids. All
cells were transfected using calcium phosphate precipitation
and harvested 48–72 h after transfection. Cells transfected for
NMDAR expression were kept in medium containing 50 M
MgCl2 to prevent Ca2-mediated toxicity.
BRAG-expressing Cell Lines—An HEK293 cell line express-
ing a 1154-amino acid isoform of BRAG1 (HEK-BRAG1) was
generated following the same protocol as forHEK-BRAG2 (13).
GST Pulldown Assay—GST fusion proteins were expressed
in Escherichia coli BL21(DE3) (Stratagene) and purified on glu-
tathione-Sepharose beads (GE Healthcare). For in vitro inter-
action studies, membrane-free extracts of transfected HEK293
cells (PBS, 1% TritonTM X-100, 1 CompleteTM protease
inhibitormixture, pH 7.4) were precleared by incubationwith a
mixture of unloaded and GST-coupled glutathione beads and
then incubatedwith beads coupled to the recombinant proteins
for 2 h at 4 °C. Beads were washed in PBS containing 0.1% Tri-
ton X-100.
Arf6 Activity Measurements—To determine cellular Arf6
activities, an Arf6GTP-specific pulldown assay (28) was used as
described previously (13).
HEK293 cells were starved for 1 h in ECS (140 mM NaCl, 1.3
mM CaCl2, 5.4 mM KCl, 25 mM HEPES, 33 mM glucose, pH 7.4)
and then stimulated with 1 mM L-glutamate (Applichem) for 5
min in ECS. To test the importance of calcium influx, HEK293
cells were starved in ECS containing 1.3 mM CaCl2 for 1 h,
washed with ECS without CaCl2, and then stimulated with 1
mM L-glutamate in ECS with or without 1.3 mM CaCl2.
Primary cortical cultures were infected at DIV2 or DIV15.
They were treated at DIV6–8 or DIV20–22 (referred to as
DIV7 and DIV21 in the figures) with 100 M D-AP5 (Tocris),
100 M ()-MK-801 maleate (Tocris), 3 M ifenprodil ()-
tartrate salt (Sigma-Aldrich), 300 nM ZnCl2 (Applichem),
and/or 100 M NMDA (Biotrend) in conditioned medium as
indicated.
Arf6 activity was quantified by comparing background-cor-
rected signal intensity densities of Arf6 pulldown (pd) and Arf6
total (t) bands on immunoblots. Band intensities were mea-
sured on the blot imager Fusion FX7 (Vilber Lourmat). Inten-
sity values were obtained by Bio1D (Vilber Lourmat) and
calculated withMicrosoft Excel as pd/t ratios or effect percent-
ages. GraphPad Prism version 5 for Windows was used for
graphs and statistical analysis.
Results were expressed as means of active Arf6 ratios (pd/t)
S.E. fromat least three independent experiments and six inde-
pendent values. In the case that test groups were compared in
pairs of treated and untreated samples, activity ratios are shown
as effect percentages comparedwith the untreated control. Sta-
tistical significance was evaluated by two-tailed unpaired or
paired t tests as indicated. Differences were considered signifi-
cant (*) at p values of less than 0.05.
Immunocytochemistry—HEK-BRAG1 and -BRAG2 cells
were plated on poly-DL-ornithine hydrobromide-coated cover-
slips and transfected either for expression of Arf6-HA, GluN1,
GluN2A, or GluN2B or for expression of Arf6, GluN1, and
HA-GluN2A or HA-GluN2B. 24 h later, cells were fixed with
4% paraformaldehyde, permeabilized with 0.25%Triton X-100,
blocked in 1% BSA, and incubated with primary antibodies
overnight at 4 °C in 1% BSA. HEK-BRAG1 cells were stained
with antibodies to BRAG1 (HPA003973; 1:100) and HA
(1:1,000); HEK-BRAG2 cells were stained with antibodies to
BRAG2 (IC; 1:500) and HA (1:1,000). Secondary Alexa Fluor
fluorophore-conjugated antibodies were applied 1:1,000 for 1 h
at room temperature, and the cells were mounted withMowiol
4-88 (Sigma-Aldrich). Images of 0.4-m-thick sliceswere taken
on an SP8 confocal system (Leica Microsystems, Germany).
Hippocampalmouse or rat neurons were infected at DIV2 or
DIV15. At DIV8 or DIV21–28, the cells were fixed with 4%
paraformaldehyde, permeabilized with 0.25% Triton X-100,
and blocked in 1% BSA. Primary antibodies to VGLUT 1
(1:1,000), PSD-95 (1:1,000), BRAG1 (HPA003973; 1:100),
BRAG2 (IC; 1:500), GluN2A (1:200), GluN2B (1:200), Arf6
(1:100), Homer1b/c (1:1,000), and GFP (1:1,000) were applied
overnight at 4 °C in 1% BSA. Secondary Alexa Fluor fluoro-
phore-conjugated antibodies (1:1,000) were applied for 1 h at
room temperature in 1% BSA and mounted with Mowiol.
Images were taken on an SP8 confocal system.Maximal projec-
tions of Z-stacks were further analyzed in ImageJ. Synapse
numbers and sizes were quantified as described (29).
Fluorescence Internalization Assay—Hippocampal rat neu-
rons were infected at DIV15 and used at DIV24/25. Neurons
were treated under live conditions at 37 °C, 5% CO2 in their
medium first for 10 min with mouse anti-GluA2 antibody
(1:100). After three brief washings with conditioned medium,
cells were stimulated with 100 M NMDA for 3 min, washed
oncewithmedium, and incubated for an additional 7min. Cells
were then mildly fixed with 4% paraformaldehyde for 5 min,
washed with PBS, blocked with 1% BSA for 30 min at room
temperature, and incubated with Cy5-conjugated anti-mouse
antibody (Jackson ImmunoResearch Laboratories; 1:500) in 1%
BSA to visualize surface GluA2. After washing with PBS, cells
were fixed and permeabilized with a 9:1 mixture of methanol
and MES solution (100 mM MES (AppliChem), pH 6.9, 1 mM
EDTA, 1 mM MgCl2) for 90 s at 20 °C. Cells were again
blocked for 30 min with 1% BSA, and chicken anti-GFP anti-
body (1:1,000) was applied for 1 h at room temperature. After
washing with PBS, Cy3-conjugated anti-mouse antibody (Jack-
son ImmunoResearch Laboratories; 1:500) and Alexa Fluor
488-conjugated anti-chicken antibody (1:1,000) were applied
for 1 h in 1% BSA. Coverslips were washed and mounted in
Mowiol.
GFP-positive neurons were inspected on an SP5 confocal
system (Leica Microsystems). The ratio of the mean intensities
for Cy5 representing surface-remaining GluA2 and Cy3 repre-
senting intracellular GluA2 in segments of proximal dendrites
was measured using ImageJ.
Animal Procedures—All animal procedures were in accord-
ance with the “European Union’s Directive 86/609/EEC” and
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the Regional Boards in Berlin (G-0268/09, T-0269/11) and
Karlsruhe (35-9185.81/G-273/12).
Electrophysiology in Berlin (Fig. 9)—Adeno-associated virus
constructs expressing shRNA were injected unilaterally in the
hippocampus of postnatal day 0 (P0) (BRAG1 RNAi or BRAG2
RNAi) and P21 (BRAG2 RNAi) mice. For viral injections in P0
mice, pups were briefly anesthetized with isoflurane. Viral con-
structs were directly injected in the hippocampal region at
three different spots along the ventrodorsal axis 20 m apart.
The virus was pressure-injected using borosilicate glass capil-
laries (World Precision Instruments) pulled with a Zeitz DMZ
Puller (Martinsried, Germany). For stereotaxic injections in
P21 mice, animals were anesthetized with ketamine/xylazine
(100 and 10mg/kg, respectively). Hippocampal injections were
done using the following coordinates (relative to bregma):
medial/lateral, 3.60 mm; anterior/posterior, 3.28 mm; dorsal/
ventral, 2.96mm.Virus was injected at three spots 50mapart,
0.25 l each using capillary micropipets (Drummond). At least
2 weeks after infection, mice were briefly anesthetized with iso-
flurane and decapitated. Brains were rapidly removed and
transferred to cooled oxygenated artificial cerebrospinal fluid
containing 87 mM NaCl, 26 mM NaHCO3, 50 mM sucrose, 10
mM glucose, 2.5 mM KCl, 1.25 mMNaH2PO4, 3 mMMgCl2, and
0.5 mM CaCl2. Horizontal hippocampal slices (300 m) were
cut on a VT 1200 Vibratome (Leica Microsystems). Slices were
then incubated at 34–35 °C in an interface-type storing cham-
ber, and recordings were started after 1 h. All recordings were
performed in artificial cerebrospinal fluid containing 119 mM
NaCl, 26 mM NaHCO3, 10 mM glucose, 2.5 mM KCl, 1 mM
NaH2PO4, 1.3mMMgCl2, and 2.5mMCaCl2 at near-physiolog-
ical temperature (34 °C). All artificial cerebrospinal fluid
solutions were equilibrated with 95%O2 and 5%CO2; osmolar-
ity of artificial cerebrospinal fluid for recordings was main-
tained in the range of 290 and 305 mosM. Whole-cell patch
clamp recordings were performed in a submerged recording
chamber. For recordings, borosilicate glass electrodes (2–5
megaohms) were used filled with 130 mM KMeSO3, 10 mM
HEPES, 20 mM KCl, 4 mM NaCl, 4 mM Mg-ATP, 0.5 mM Na-
GTP, and 5 mM sodium phosphocreatine; pH of the intracellu-
lar solution was adjusted to 7.2 with KOH. To isolate AMPAR
miniature excitatory postsynaptic currents (mEPSCs), 1 M SR
95531 (gabazine), 1M tetrodotoxin, 50M D-AP5, and 100M
cyclothiazide were added to the extracellular recording solu-
tion. Principal cells located in the pyramidal cell layer of the
hippocampal CA1 area were identified using infrared differen-
tial interference contrast video microscopy and adequate fluo-
rescence filter settings visualizing GFP-tagged neurons. Series
resistance (Rs) was monitored throughout experiments; cells
were rejected if Rs was 20 megaohms. No Rs compensation
was used. Collected signals were digitized with 16-bit resolu-
tion (National Instruments, Austin, TX) and sampled at 3 kHz
using Igor Pro (Wavemetrics, Lake Oswego, OR). For mEPSC
analysis, data were filtered to 1 kHz. For mEPSC collection,
signals were first detected automatically using the Igor plug-in
Neuromatics and in a second step manually sorted by visual
inspection to exclude false positive events.
Electrophysiology in Mannheim (Fig. 10)—Surgeries of 3–4-
week-old Iqsec1fl/fl mice were carried out as described (13).
Viral stock of FCKiGW-Cre was injected into the left hip-
pocampus using the following coordinates (relative to breg-
ma): anterior/posterior, 2.6 and 2.9 mm; medial/lateral, 3.5
mm; and dorsal/ventral, 3.4–2.2 mm (every 300 m about
130 nl). Acute transverse slices (280 m) from the middle
hippocampus were prepared at least 2 weeks after infection
at 5–7 weeks of age and perfused, cut, and stored in a sub-
merged chamber with sucrose saline (125 mM NaCl, 25 mM
NaHCO3, 2.5 mM KCl, 1.25 mM NaH2PO4, 7 mM MgSO4, 0.5
mM CaCl2, 10 mM glucose, and 65 mM sucrose bubbled with
95% O2 and 5% CO2; 300 mosM).
EPSCs were evoked with biphasic electrical stimulation in
stratum radiatum (100–150 m from stratum pyramidale
and shifted toward subiculum). In whole-cell voltage clamp
with Cfast and Rs compensated for, EPSCs were recorded at
room temperature in a submerged chamber from green fluo-
rescent CA1 pyramidal cells (EPC10, HEKA, Patchmaster soft-
ware) in saline (125 mM NaCl, 25 mM NaHCO3, 2.5 mM KCl,
1.25 mM NaH2PO4, 1 mM MgSO4, 2 mM CaCl2, 12.5 mM glu-
cose, and 0.005mM gabazine bubbledwith 95%O2 and 5%CO2;
300 mosM) with internal pipette solution (0.2 mM EGTA, 10
mM HEPES, 125 mM cesium gluconate, 20 mM CsCl, 10 mM
NaCl, 10 mM Na2-phosphocreatine, 4 mM Mg-ATP, 0.3 mM
Na3-GTP, and 5 mM QX-314 chloride, pH 7.3; 280 mosM).
Control EPSCs were recorded from uninfected cells from the
right hemisphere. AMPAR currents were recorded at70mV,
and NMDAR currents were recorded at40 mV after wash-in
of 5 M 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxa-
line-7-sulfonamide. Rise of NMDAR currents was determined
by the slope of a 20–80% linear fit normalized to the respective
amplitude, decay of NMDAR current by amonoexponential fit,
and paired pulse ratios with an interstimulus interval of 50 ms.
The coefficient of variation (CV) was the ratio of standard devi-
ation and average EPSC amplitude per cell (15–30 repetitions
per cell). Mean EPSC was plotted against inverse squared CV
(CV2) assuming that (i) CV2 	 n  Pr/(1  Pr) with a con-
stant average release probability of Pr 	 0.3 (30) and (ii) mean
EPSC is proportional to the number n of stimulated synapses
and to the number of actually releasing synapses, which we call
nr (nr	 n Pr). Therefore, quantal size q is proportional to the
slope of a linear fit through the origin, i.e. q 	 slope/(1  Pr)
because CV2	 nr/(1 Pr) and mean EPSC	 q nr.
Statistical significances (*, p 
 0.05) were assessed in
GraphPad Prism 5.02 or Igor Pro 6.36 (Wavemetrics) via t test if
not indicated otherwise.
Results
NMDARs Stimulate BRAG1 and BRAG2 in a Subtype-selec-
tive Manner in HEK293 Cells—To assess potential signaling
from NMDARs to BRAGs, we co-expressed diheteromeric
NMDARs consisting of GluN1 and either GluN2A or GluN2B
and BRAG1 or BRAG2 in HEK293 cells and measured changes
in Arf6 activity following stimulation with glutamate (Fig. 1A).
GluN2B-containing NMDARs triggered an increase in the
Arf6-GTP level through BRAG1. Vice versa, activation of
GluN2A-containingNMDARs increased theArf6 activity upon
co-expression with BRAG2. In contrast, in cells expressing
GluN2B and BRAG2 or GluN2A and BRAG1, the Arf6 activity
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was decreased by the glutamate treatment. Omission of cal-
cium from the extracellular solution during stimulation pre-
vented glutamate-triggered Arf6 activation, indicating that
NMDAR-BRAG signaling requires calcium influx (Fig. 1B).
BRAG1, BRAG2, and Arf6 were enriched at sites close to the
plasma membrane in line with their regulation by surface-
expressed NMDARs (Fig. 1C). Thus, it appears that the
closely related Arf6 GEFs BRAG1 and BRAG2 are able to
mediate calcium-dependent, subtype-specific functions of
the NMDAR.
NMDAR-BRAG Signaling Depends on Binding Sites in the
GluN2C-terminal Tails—WeusedGSTpulldown assays to test
for interactions between the intracellular domains of GluN2
subunits and BRAGs (Fig. 2). A 200-amino acid region centrally
located within the intracellular domain of GluN2A bound
BRAG2 (Fig. 2A). In a calcium-free buffer, this fragment of
GluN2A as well as the corresponding region of GluN2B pulled
down both BRAGs without preference. In contrast, in the pres-
ence of 100 M Ca2, GluN2A pulled down less BRAG1 than
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FIGURE 1. Ligand binding to NMDARs stimulates BRAG-mediated Arf6
activation in a subtype-selective and Ca2-dependent manner. A, sub-
type-selective stimulation of BRAG1 and BRAG2 by ligand binding to
NMDARs in HEK293 cells. Shown are representative immunoblots of Arf6GTP-
specific pulldown assays from HEK-BRAG1 and HEK-BRAG2 cells expressing
Arf6-HA, GluN1, and either GluN2A or GluN2B. Bars illustrate Arf6 activation
calculated as the Arf6GTP/Arf6total ratio (pd/t) of cells treated for 5 min with 1
mM L-glutamate (glu) normalized to untreated controls (paired t test: HEK-
BRAG1:GluN2A, *,p	0.0099,n	9; GluN2B, *,p	0.0033,n	7;HEK-BRAG2:
GluN2A, *, p 	 0.043, n 	 6; GluN2B, *, p 	 0.025, n 	 6). B, NMDAR-BRAG
signaling requires Ca2. Shown are representative immunoblots of Arf6GTP-
specific pulldown assays from HEK-BRAG1 cells expressing Arf6-HA, GluN1,
and GluN2B and from HEK-BRAG2 cells expressing Arf6-HA, GluN1, and
GluN2A. Cells were stimulated by application of an extracellular solution con-
taining L-glutamate (glu) with or without 1.3 mM Ca2. Bars illustrate Arf6
activation calculated as the Arf6GTP/Arf6total ratio (pd/t) of cells treated with
glutamate in the presence or absence of extracellular Ca2 normalized to
untreated controls (paired t test: HEK-BRAG1: without (w/o) Ca2, p 	 0.63,
n	 11; with Ca2, *, p	 0.0009, n	 6; HEK-BRAG2: without Ca2, p	 0.88,
n 	 8; with Ca2, *, p 	 0.010, n 	 6). Error bars indicate S.E. C, subcellular
distribution and expression levels of NMDARs, BRAGs, and Arf6 in trans-
fected HEK-BRAG1 and -BRAG2 cells. NMDARs with HA-tagged GluN2 sub-
units and untagged Arf6 were expressed to compare the localization of
GluN2B and BRAG1 or GluN2A and BRAG2 (left column). NMDARs with
untagged GluN2 subunits and Arf6-HA (right column, as in A and B) were
expressed to compare the localization of BRAG1 or BRAG2 and Arf6. The
distribution of the stained proteinswas similar upon expression of GluN2A
in HEK-BRAG1 and GluN2B in HEK-BRAG2 cells (not shown).Western blots
show the expression levels of GluN2 subunits, BRAGs, and Arf6-HA in
homogenates of HEK-BRAG1 and HEK-BRAG2 cells transfected as in A and
B. Scale bar, 10 m.
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FIGURE 2. Physical interaction between NMDARs and BRAG proteins. A,
the central part of the intracellular domain of GluN2A binds to BRAG2. An
immunoblot of recombinant FLAG (F)-tagged BRAG2 pulled down from a
HEK293 cell extract by GST fused to aa 838–1037 (GluN2A-CT200a), aa 1038–
1237 (GluN2A-CT200b), and aa 1238–1464 (GluN2A-CT227) of GluN2A in the
presence of 2 mM EDTA is shown. GluN2A-CT200a was recovered from inclu-
sion bodies (50). Input, 5% of cell extract. B, Ca2 promotes selective interac-
tions between GluN2 fragments and BRAGs. Immunoblots of recombinant
FLAG-tagged BRAG2 or BRAG1 recovered from HEK293 cell extracts by
GluN2A-CT200b and by GST fused to aa 1036–1243 of GluN2B (GluN2B-
CT208) in the presence of 2mM EDTA or 100M Ca2 are shown. Input, 5% of
cell extract. C, BRAGs interact with short regions in GluN2 subunits. Immuno-
blots of recombinant FLAG-tagged BRAG proteins recovered from HEK293
cell extracts by GST pulldown with 40- or 100-amino acid fragments of
GluN2A (GluN2A-CT100a, aa 1038–1137; GluN2A-CT100b, aa 1138–1237;
GluN2A-CT40a, aa 1058–1097; GluN2A-CT40b, aa 1078–1117; GluN2A-
CT40c, aa 1098–1137) and GluN2B (GluN2B-CT40a, aa 1115–1154; GluN2B-
CT40b, aa 1135–1174; GluN2B-CT40c, aa 1155–1194) in the presence of 2mM
Ca2. Input, 5% of cell extract. D, interaction sites for BRAG2 and BRAG1
within GluN2 intracellular C-terminal tails. The scheme indicates the location
of the protein fragments used for the interaction analyseswithin the C-termi-
nal regions of GluN2A andGluN2B. NMDAR fragments shown to interactwith
BRAG1 or BRAG2 are depicted in green. Sequences of the shortest interacting
fragments in single letter code of amino acids are shown below with con-
served motifs in red and blue. Importance of the KTK/RTK motif (bold) was
tested in Fig. 3.
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GluN2B, whereas BRAG2 was pulled down exclusively by
GluN2A (Fig. 2B). This finding suggests that calcium has an
impact on the interaction between NMDARs and BRAG pro-
teins. Further mapping of the BRAG binding sites within
GluN2A andGluN2B revealed 40-amino acid fragments able to
interact with BRAGs in the GST pulldown assay (Fig. 2, C and
D). Glutamate stimulation of NMDARs lacking these regions
either decreased the Arf6 activity (Fig. 3A) or had no effect on
theArf6-GTP level (Fig. 3B) in contrast to full-length receptors.
These data indicate that both a rise in the calcium concentra-
tion and interaction sites in the cytoplasmic region of the
GluN2 subunits are required for the activation of BRAG1 and
BRAG2.
A comparison of the GluN2 sequences interacting with
BRAG1 and BRAG2 revealed two short stretches of conserved
amino acids (Fig. 2D). Interestingly, they are present in the
opposite order in GluN2A and GluN2B. Mutation of KTKDN
to AAADN in GluN2A and RTKEN to AAAEN in GluN2B
prevented the glutamate-triggered Arf6 activation through
NMDARs and BRAGs in HEK293 cells (Fig. 3, A and B). This
result suggests that the amino acids 1081KTK1083/1138RTK1140
in GluN2A/2B are required for signal transduction from
NMDARs to BRAGs.
BRAGsMediateNMDAR-drivenArf6Activation inNeuronal
Cultures—It is well established that NMDARs are restricted to
GluN2B or GluN2D in terms of GluN2 subunit expression at
embryonic stages, whereas during postnatal development the
contribution of GluN2A is continuously increasing (3–5). We
therefore chose to analyzeNMDAReffects on endogenousArf6
in primary cortical neuron cultures at a young (DIV6–8) and at
a mature (DIV20–22) stage. The expression levels of BRAG1,
BRAG2, and GluN2A were much higher in mature than in
young neurons, whereas GluN2B and Arf6 showed only minor
changes (Fig. 9D). In young cultures, we found the Arf6 activity
to be significantly higher than inmature cultures (Fig. 4A). The
Arf6 activity of young neurons was decreased by both the
NMDAR antagonist D-AP5 (Fig. 4A) and the NMDAR channel
blocker MK-801 (Fig. 4B), suggesting an endogenous stimula-
tory NMDAR activity on Arf6 at this stage. We tried to isolate
subtype-selective effects using 3 M ifenprodil to prevent
activation of heterodimeric GluN1/GluN2B NMDARs or 300
nM Zn2, which blocks preferentially GluN2A-containing
NMDARs at this concentration (31–34). The endogenous
NMDAR signaling on Arf6 in young neurons was blocked by 3
M ifenprodil but not by 300 nM Zn2, suggesting it was medi-
ated by GluN2B (Fig. 4B). Next, we infected neurons at DIV2
with lentiviral vectors expressing short hairpin RNAs to deplete
BRAG1 or BRAG2. Ifenprodil reduced the Arf6 activity in con-
trol (scrambled shRNA)- andBRAG2-RNAi-infected but not in
BRAG1-RNAi-infected neurons at DIV7 (Fig. 4, C and D). In
the absence of BRAG1, ifenprodil actually increased the Arf6
activity, suggesting a negative tone of GluN2B on Arf6 under
these conditions. These data indicate that BRAG1 is mediating
endogenous GluN2B-dependent signaling on Arf6 in young
neuronal cultures.
In mature neurons, application of D-AP5 did not decrease
the Arf6-GTP level (Fig. 4A), but stimulation with NMDA
for 5 min caused an activation of Arf6 that was blocked by
D-AP5 or MK-801 (Fig. 5A). The NMDA-triggered Arf6 acti-
vation in mature neuronal cultures was not affected by 3 M
ifenprodil, indicating that it was not mediated by GluN1/
GluN2B receptors and that it might be caused by NMDARs
containing GluN2A. Indeed, the NMDA stimulus did not
lead to an activation of Arf6 in the presence of 300 nM Zn2.
Next, we infected neurons at DIV15 to deplete BRAG1 or
BRAG2 in mature neurons and found that NMDA-triggered
activation of Arf6 at DIV21 specifically relied on BRAG2
(Fig. 5, B and C). In the absence of BRAG2, NMDA caused a
drop in Arf6 activity. Thus, in line with our experiments in
HEK293 cells, NMDARs containing GluN2A signal through
BRAG2. In summary, during the development of cortical
neurons in culture, the two major NMDAR subtypes of the
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forebrain lacking or containing GluN2A triggered GDP/
GTP exchange on Arf6 through BRAG1 or BRAG2,
respectively.
Surprisingly, mature neurons infected for BRAG2 RNAi at
DIV15 displayed an increased basal activity of Arf6 that was
sensitive to ifenprodil in contrast to control-infected neurons
(Fig. 6A). Thus, the knockdown of BRAG2 in mature neurons
resulted in GluN2B-mediated Arf6 activation reminiscent of
the situation in young neurons (Fig. 4B). To check whether the
ifenprodil-sensitive Arf6 activity depended on BRAG1, we
infected neurons with a vector for RNAi against both BRAG1
andBRAG2 atDIV15. Although this approachwas less efficient
in reducing the expression of BRAG1 and BRAG2 as com-
pared with the respective single knockdowns (Fig. 4C), it
entirely blocked NMDA-triggered Arf6 activation in mature
neurons (Fig. 5B). Neurons carrying the knockdown con-
struct for both BRAGs had a low Arf6 activity that was not
sensitive to ifenprodil, suggesting that BRAG1 mediates
GluN2B-triggered Arf6 activation inmature neurons lacking
BRAG2 (Fig. 6A). Treatment of mature cultures with 300 nM
Zn2 had a similar effect as the knockdown of BRAG2: an
increased basal ifenprodil-sensitive Arf6 activity that was
prevented by a knockdown of BRAG1 applied at DIV15 (Fig.
6B). These data imply that an interference with the GluN2A-
BRAG2 pathway in mature synapses reinstalls GluN2B-
BRAG1 signaling.
Together, our Arf6 activity measurements suggest that
BRAG1 mediates tonic GluN2B-triggered Arf6 activation in
young neurons in culture, whereas in mature neurons BRAG2
mediates GluN2A-triggered Arf6 activation upon NMDAR
stimulation. This developmental shift appears to be reversible
as depletion of BRAG2 or GluN2A blockade inmature neurons
resulted in a high Arf6 activity mediated by GluN2B and
BRAG1.
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indicating times of infection and experiment (black arrows). Error bars indicate S.E. Left, representative immunoblots.D, the distribution and expression level of
GluN2B were not affected by BRAG1 depletion in young neuronal cultures. Left, at DIV8, BRAG1 co-localized with the synaptic marker VGLUT 1 in mouse
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activation by GluN2B and BRAG1 in mature cortical cultures upon depletion of BRAG2. Cultured cortical neurons (DIV21) infected at DIV15 with lentiviral
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ctrl, *,p
 0.0001,n	 10–13; BRAG1/2-KD versus ctrl,p	 0.86,n	 6–10). Levels of Arf6 activity are shownasArf6GTP/Arf6total ratios (pd/t).B andC, tonic
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Arf6GTP/Arf6total ratios (pd/t). Error bars indicate S.E. Left, representative immunoblots.
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Effects of BRAG1 and BRAG2 Depletion on the Number and
Size ofGlutamatergic Synapses in PrimaryNeuronal Cultures—
We examined synapses in mature neuronal cultures by co-
staining the presynapticmarker VGLUT1 and the postsynaptic
marker PSD-95. The knockdown of either BRAG1 or BRAG2
reduced the number of overlapping puncta by about 20%.How-
ever, the knockdown of BRAG2 diminished the average total
size of the overlapping puncta, whereas the knockdown of
BRAG1 did not affect the size of synaptic contacts (Fig. 7). The
reduced synapse sizemay be related to the increasedArf6 activ-
ity that occurred upon knockdown of BRAG2 but not upon
knockdown of BRAG1 in mature neuronal cultures (Fig. 6, A
and C).
Effects of BRAG1and BRAG2 Depletion on NMDA-triggered
AMPA Receptor Internalization in Primary Neuronal
Cultures—NMDARs control AMPAR trafficking to fine-tune
synaptic transmission. We asked whether BRAG1 or BRAG2
was involved in NMDA-triggered internalization of the princi-
pal AMPAR subunit GluA2 in dendritic segments of mature
hippocampal neurons in culture (Fig. 8). NMDAR stimulation
increased GluA2 internalization in control-infected neurons.
RNAi-mediated knockdown of BRAG2, but not of BRAG1,
interfered with this effect. However, in neurons lacking
BRAG2, GluA2 internalization prior to stimulation was higher
than in control-infected neurons, potentially occluding the
NMDA effect. As the knockdown of BRAG2 in mature cortical
cultures resulted in an increased Arf6 activity (Fig. 6A) and
precluded NMDA-triggered Arf6 activation (Fig. 5C), these
data are consistent with a role of BRAG2-mediated Arf6 acti-
vation in NMDA-triggered GluA2 internalization in mature
neurons.
Effects of BRAG1 and BRAG2 Depletion on Spontaneous
AMPAR mEPSCs in Hippocampal CA1 Pyramidal Neurons—
To analyze the effects of BRAG1 and BRAG2 on functional
synapses during development, we injected adeno-associated
virus constructs expressing the shRNAs targeting BRAG1 or
BRAG2 into the hippocampal region ofmice shortly after birth.
Spontaneous AMPAR mEPSCs were recorded from infected
(BRAG1 knockdown (KD) and BRAG2-KD) and uninfected
(ctrl) CA1 pyramidal neurons around P16. Whereas BRAG2
depletion did not affect mEPSC frequency or amplitude in this
setting (Fig. 9B; ctrl, n	 7 versusBRAG2-KD, n	 9; frequency,
p 	 0.88; amplitude, p 	 0.70), knockdown of BRAG1
decreased the frequency but not the average amplitude (Fig. 9A;
ctrl, n 	 12 versus BRAG1-KD, n 	 14; frequency, p 	 0.048;
amplitude, p	 0.23).
To test whether BRAG2 signaling exerts its impact in adult
animals, we injected the viral construct for BRAG2RNAi at P21
and recorded mEPSCs starting at P35. Now BRAG2 knock-
down significantly reduced the frequency of synaptic events to
levels seen in P16 neurons but did not alter their average ampli-
tude (Fig. 9C; ctrl, n	 7 versus BRAG2-KD, n	 8,; frequency,
p	 0.003; amplitude, p	 0.92).
The hippocampal expression levels of BRAG1, BRAG2, and
GluN2A but not of GluN2B and Arf6 increased between P14
and P36, although the differences were smaller than in rat cor-
tical cultures between DIV8 and DIV22 (Fig. 9D). In addition,
the GluN2A/GluN2B ratio was much higher in the hippocam-
pus than in the cortical cultures.
We also compared the relative frequencies of miniature
amplitudes after knockdown of BRAG1 or BRAG2 using an
equal number of events per cell and condition to prevent over-
representation of single cells. The relative frequency distribu-
tion of mEPSCs in young neurons infected for BRAG1 RNAi at
P0 (Fig. 9A) and of mature CA1 neurons lacking BRAG2 (Fig.
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9C) revealed a shift to smaller amplitudes as compared with
uninfected neurons (Kolmogorov-Smirnov test, p 
 0.0001).
We cannot exclude that the amplitude shift results in a reduc-
tion of the mEPSCs to a level below the detection limit in a
subset of synapses, thereby contributing to the reducedmEPSC
frequencies. In contrast, BRAG2 RNAi at P0 did not affect
the relative frequency distribution of mEPSC amplitudes
(Fig. 9B). Together, these results corroborate that signaling
through BRAG1 and BRAG2 is critical at different points in
development, although the expression of both BRAG1 and
BRAG2 in mouse forebrain was detectable at P1 and
increased steadily afterward (Fig. 9D). In addition, the
altered amplitude spectra and the reduced mEPSC frequen-
cies suggest that BRAG depletion reduced the strength and
the number of synapses.
Effects of BRAG2Depletion on the Properties of Evoked EPSCs
in Mature Hippocampal CA1 Pyramidal Neurons—We next
tested whether the increased GluN2B-mediated effects on Arf6
that we observed upon down-regulation of BRAG2 in cultured
neurons (Fig. 6A) would manifest in a change of the synaptic
NMDAR subunit composition in mature hippocampal CA1
pyramidal neurons of mice. To this end, we infected mice car-
rying loxP elements in the gene for BRAG2 (Iqsec1fl/flmice) (13)
with a lentiviral Cre expression vector at 3–4 weeks of age.
Two weeks later, isolated AMPAR and NMDAR currents
were recorded from CA1 pyramidal neurons upon Schaffer
collateral stimulation in acute slices (Fig. 10A). We did not
observe any difference in the kinetic profile of NMDAR cur-
rents upon Cre infection (Fig. 10B; ctrl, n 	 14 versus
BRAG2, n 	 7; rise, p 	 0.38; decay, p 	 0.57). This result
indicates that there was no increased participation of
GluN1/N2B heterodimers in the synaptic NMDARs of cells
lacking BRAG2 as this would have prolonged both the rise
and decay of their currents (9, 35).
The ratio between the peak amplitudes of AMPAR and
NMDAR currents was increased to some extent in BRAG2
knock-out cells as compared with controls (Fig. 10C; ctrl, n 	
14 versus BRAG2, n 	 7; p 	 0.048, Mann-Whitney test),
suggesting a relative gain of AMPAR current and/or a relative
loss of NMDAR current in mature CA1 neurons lacking
BRAG2. A significant fraction of synapses onmature CA1 neu-
rons contains functional NMDARs but lacks physiological
AMPAR currents and is therefore called silent synapses (1, 30,
36–38). The CV was significantly different between AMPAR
and NMDAR currents in uninfected but not in BRAG2 knock-
out neurons (Fig. 10D; AMPAR versus NMDAR; ctrl, n 	 14,
p 	 0.0015; BRAG2, n 	 7, p 	 0.20), indicating a relative
reduction in the number of silent synapses that may contribute
to the increase in the AMPA/NMDA ratio. Paired pulse ratios
were not altered by Cre infection (Fig. 10E; ctrl, n 	 6 versus
BRAG2, n	 9; p	 0.62), suggesting no change in the release
probability of glutamate. This allowed us to deduce the
AMPAR and NMDAR quantal sizes from the relation of the
mean EPSCs with their corresponding CV2, which served as a
measure of the number of activated synapses (Fig. 10F).
AMPAR and NMDAR quantal sizes were significantly reduced
in cells lacking BRAG2 (ctrl, n 	 20 versus BRAG2, n 	 16;
p	 0.025 for AMPAR; ctrl, n	 14 versus BRAG2, n	 7; p	
0.018 for NMDAR; linear regression F-test). Thus, CA1 neu-
rons lacking BRAG2 had fewer AMPAR-silent synapses and
lower AMPAR and NMDAR currents per Schaffer collateral
synapse.
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Discussion
Here we report interactions between NMDARs and BRAG
proteins that mediate an activity-dependent regulation of neu-
ronal Arf6-GTP levels. We previously found that the AMPAR
subunit GluA2 stimulates BRAG2 in the course of LTD trig-
gered by metabotropic glutamate receptors (13). Thus, BRAG
stimulation appears to represent a general function of iono-
tropic glutamate receptors, ensuring a tight link between syn-
aptic activity and BRAG-mediated Arf6 activation.
Ligand-bound NMDA receptors stimulate the GEF activity
of BRAG1 and BRAG2 by calcium influx and by the large intra-
cellular domains of GluN2B and GluN2A. The GluN2 subunits
recruit a differential set of GEFs for the small GTPases Ras and
Rac1 as well (39–42). The fact that closely related GEFs asso-
ciate with the C-terminal tails of GluN2A and GluN2B lends
further support to the idea that gene duplication and paralog
diversification increased the variety of postsynaptic signal
transduction complexes (43). Quantitative mass spectrometry
revealed that the numbers of BRAG1andBRAG2molecules per
average PSD in adult rat cerebral cortex are in a similar range as
that of NMDARs (around 10% of PSD-95), confirming their
availability as postsynaptic binding partners (14). In the
absence of BRAG1 or BRAG2, we frequently observed Arf6-
GTP hydrolysis upon NMDAR stimulation. Thus, Arf6 is most
likely regulated by synaptic pairs of GEFs and GTPase-activat-
ing proteins as shown for Rac1 (44). The NMDAR complex
contains AGAP3, a GTPase-activating protein for Arf6 (45),
that may be a candidate GTPase-activating protein partner of
BRAG2.
We identified short regions within the C-terminal tails of
GluN2A and GluN2B that mediate an interaction with BRAGs
and are critical for signaling fromNMDARs to BRAGs in vitro.
These regions may serve as targets to manipulate NMDAR-de-
pendent Arf6 activation in neurons. The interaction between
GluN2 subunits and BRAGs may involve additional binding
sites and/or proteins. Furthermore, PSD-95 family members
may stabilize or coordinate NMDAR-BRAG complexes.
An increase in the intracellular calcium concentration was
required for NMDAR-BRAG signaling in HEK293 cells, and
calcium promoted selective interactions between NMDARs
and BRAGs. The calcium sensor calmodulin interacts with the
IQ-likemotif of BRAG1 (15) and BRAG2 (data not shown) only
in the absence of calcium.Calcium-triggered release of calmod-
ulin induced a conformational change in BRAG1 (15). The cal-
cium-sensitive calmodulin binding may modulate the interac-
tions of BRAGs with GluN2 subunits and thereby contribute to
the regulation of NMDAR-BRAG signaling.
Our experiments in primary cortical neurons revealed that
GluN2B-BRAG1 signaling is replaced by GluN2A-BRAG2 sig-
naling over time. In young but not in mature cultures, we
detected tonic GluN2B-BRAG1 signaling that may contribute
to the Arf6-dependent morphological maturation of dendritic
spines (18, 19) and/or to the relatively low plasticity threshold
of young synapses (46). In mature neurons, NMDAR-depen-
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FIGURE 9. Loss of BRAG1 or BRAG2 alters AMPAR mEPSC frequency and amplitude distribution in CA1 pyramidal neurons. A–C, the impact of
BRAG1 or BRAG2 signaling on synaptic transmission during development was assessed by recording of spontaneous AMPAR mEPSCs at a holding
potential of70 mV. Recordings were performed around P16 for P0-injected mice using viral constructs for shRNA to BRAG1 (A) or shRNA to BRAG2 (B)
or after P35 for P21-injected mice using shRNA to BRAG2 (C). Example traces for uninfected (ctrl) and infected cells are shown below the experimental
timelines indicating times of infection and experiment (black arrows). Data are plotted for mEPSC frequency and amplitude and reported as mean S.E.
(error bars); *, p 
 0.05 using Student’s unpaired t test. Relative frequency distribution plots for 5-pA bins are shown on the bottom (amplitude values
indicate the center of each bin). These plots contain data sets of an equal number of events per cell and condition to prevent overrepresentation of
single cells. D, expression levels of NMDAR subunits, BRAGs, and Arf6 in postnatal mouse hippocampi and in rat cortical neuron cultures (top) as well as
duringmouse forebrain development (bottom). Shown are Western blots of nucleus-free tissue extracts and of neuronal culture homogenates adjusted
to obtain comparable III-tubulin immunoreactivities.
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dent Arf6 activation relied on signaling through GluN2A and
BRAG2 and was not induced by the endogenous excitation in
the culture. Therefore, the incorporation of GluN2A into
NMDARs affects not only the biophysical properties of their
currents (4, 9, 35) but also restricts Arf6 activation to strong
inputs. The tonic NMDAR-dependent Arf6 activation is shut
down during development (Fig. 4A), although both GluN2B
andBRAG1are present atmature synapses (9, 14, 35). AMPAR-
BRAG2 signaling is blocked by tyrosine phosphorylation (13),
and a posttranslational modification may prevent GluN2B-
BRAG1 signaling at the mature stage as well. However, BRAG2
RNAi in mature neurons induced a return to GluN2B-BRAG1
signaling. Thus, recruitment of BRAG2 may impair GluN2B-
BRAG1 signaling, e.g. by competitive binding to triheteromeric
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NMDARs. Application of 300 nM Zn2 reinstalled GluN2B-
BRAG1 signaling in mature neurons as well, suggesting that
GluN2A activation is required to maintain the low level of Arf6
activation. It will be interesting to see whether this phenome-
non plays a role in vivo, e.g. during prolonged inactivity of
synapses.
Measurements of AMPAR mEPSCs from hippocampal CA1
pyramidal neurons substantiated the importance of BRAG1
and BRAG2 at different stages of development. We found that
BRAG1 plays a role in the maturation of synapses onto CA1
pyramidal neurons within the first 2 weeks of life. The muta-
tions in the gene for BRAG1 identified in families with nonsyn-
dromic X chromosome-linked intellectual disability result in a
reduced GEF activity (22) and thus may affect GluN2B-BRAG1
signaling and the early postnatal development of synapses.
Although BRAG2 RNAi did not affect mEPSCs during the
first 2 postnatal weeks, it resulted in a shift to smaller ampli-
tudes and in a significantly reduced frequency of mEPSCs if
applied at P21. In accord, knockdown of BRAG2 in mature
neuronal cultures resulted in a decrease in the number as
well as the size of glutamatergic synaptic contacts and ele-
vated AMPAR internalization. Considering the tonic Arf6
activation through GluN2B-BRAG1 upon BRAG2 RNAi
described above, these effects are in line with BRAG-depen-
dent Arf6 activation mediating AMPAR internalization and
synaptic depression (13, 15). Furthermore, targeted deletion
of BRAG2 in hippocampal CA1 pyramidal neurons of P21
mice reduced the fraction of silent synapses as well as the
quantal sizes of evoked AMPAR and NMDAR currents.
Together, the loss of BRAG2 compromised the synaptic con-
nections onto CA1 pyramidal neurons.
The formation of functional synapses is thought to involve an
initial GluN2B-dependent limitation of AMPAR trafficking to
synapses and a subsequent relief from synaptic suppression
upon incorporation of GluN2A (7–9). BRAG2 depletion
reverted the drop inArf6 activity induced by the developmental
GluN2 subunit switch without altering the NMDAR subunit
composition and caused synapse weakening. Therefore, we
propose that the down-regulation of the Arf6 activity induced
by the incorporation ofGluN2Acontributes to the formation of
mature synapses.
The coordinated transition of GluN2B-BRAG1 to GluN2A-
BRAG2 signaling may be critical for synaptic selection because
it ensures that the tonic synapse-suppressing Arf6 activity is
switched off only at those connections with a strong or corre-
lated neuronal activity, whereas others get eliminated. Tonic
Arf6 activation may also contribute to metaplasticity based on
an increased participation of GluN2B in NMDARs (46–49).
We previously identified a pathway through metabotropic
glutamate receptors and AMPARs to stimulate BRAG2 and
found that neither metabotropic glutamate receptor- nor
NMDAR-dependent LTD could be induced in mature hip-
pocampal CA1 neurons lacking BRAG2 (13). The GluN2A-
BRAG2 signaling reported heremay provide an explanation for
the block of NMDAR-dependent LTD upon BRAG2 deletion.
Conversely, the suppression of synaptic currents caused by the
absence of BRAG2 may have prevented further depression
upon LTD-related stimuli.
In summary, NMDARs, via their GluN2 subunits, consecu-
tively stimulate BRAG1 and BRAG2 in the process of synapse
maturation. It will be important to address the roles of these
two pathways in homeostatic plasticity as well as in neurologi-
cal disorders.
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